Actuate Therapeutics, Inc.

NasdaqGM:ACTU Stock Report

Market Cap: US$188.5m

Actuate Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ACTU Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Aug 24BuyUS$4,000,000Bios Equity Partners LPCompany500,000US$8.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACTU?
Owner TypeNumber of SharesOwnership Percentage
Institutions273,9481.4%
Individual Insiders957,2904.9%
General Public5,687,48429.1%
VC/PE Firms12,612,91464.6%

Dilution of Shares: ACTU only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 70.88% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
51.1%
Bios Equity Partners LP
9,978,568US$96.3m0%89.8%
13.5%
Kairos Ventures Partners
2,634,346US$25.4m357%no data
3.17%
Daniel Schmitt
619,014US$6.0m8.06%no data
0.59%
Andrew Mazar
115,468US$1.1m10.6%no data
0.39%
Aaron Glenn Fletcher
77,085US$743.9k0%no data
0.39%
Daniel Zabrowski
76,348US$736.8k0%no data
0.36%
Leslie Kreis
69,375US$669.5k0%no data
0.28%
Voss Capital, LP
55,246US$533.1k0%0.04%
0.14%
Geode Capital Management, LLC
27,893US$269.2k0%no data
0.14%
Northwestern University, Endowment Arm
27,778US$268.1k0%0.48%
0.12%
Sigma Planning Corporation
23,675US$228.5k47.3%0.01%
0.11%
Goldman Sachs Group, Investment Banking and Securities Investments
22,358US$215.8k98.7%no data
0.095%
The Vanguard Group, Inc.
18,574US$179.2k29.9%no data
0.084%
Mercer Global Advisors Inc.
16,344US$157.7k0%no data
0.081%
Northern Trust Global Investments
15,799US$152.5k0%no data
0.061%
KG&L Capital Management, LLC
12,000US$115.8k0%0.04%
0.056%
SFMG, LLC
11,000US$106.2k0%0.01%
0.054%
OMERS Administration Corporation
10,583US$102.1k0%no data
0.053%
Chicago Partners Investment Group LLC
10,365US$100.0k0%no data
0.051%
Freestone Capital Management, LLC
10,000US$96.5k0%no data
0.039%
BlackRock, Inc.
7,598US$73.3k-1.9%no data
0.0099%
UBS Asset Management AG
1,934US$18.7k0%no data
0.0037%
Victory Capital Management Inc.
724US$7.0k-0.41%no data
0.0033%
Citigroup Inc.,Banking and Securities Investments
649US$6.3k32,400%no data
0.0029%
Lord, Abbett & Co. LLC
560US$5.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/15 19:21
End of Day Share Price 2025/05/15 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Actuate Therapeutics, Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gum-Ming LoweCraig-Hallum Capital Group LLC
Swayampakula RamakanthH.C. Wainwright & Co.
Christopher LiuLucid Capital Markets